David Windley
Stock Analyst at Jefferies
(3.66)
# 760
Out of 4,944 analysts
191
Total ratings
67.89%
Success rate
14%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Initiates: Hold | $263 | $247.16 | +6.41% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $2.08 | +32.53% | 1 | May 21, 2025 | |
| CNC Centene | Maintains: Hold | $64 → $61 | $27.07 | +125.34% | 28 | Apr 29, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $14.95 | -19.71% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $281.99 | -10.28% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $7.87 | +166.84% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $468.32 | -26.33% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $287.12 | +46.98% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $161.20 | +84.24% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $190.23 | +27.21% | 4 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $481 → $647 | $271.89 | +137.96% | 26 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $1.99 | +88.92% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $293.43 | +105.84% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $482.47 | -22.27% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $15.73 | -1.46% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $279.18 | -3.29% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $11.16 | +38.89% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $246.18 | +117.73% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $22.39 | +29.52% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $155.04 | +30.93% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $176.41 | +71.19% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $7.42 | +3,242.32% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.63 | - | 5 | Oct 9, 2017 |
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $247.16
Upside: +6.41%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $2.08
Upside: +32.53%
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $27.07
Upside: +125.34%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $14.95
Upside: -19.71%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $281.99
Upside: -10.28%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $7.87
Upside: +166.84%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $468.32
Upside: -26.33%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $287.12
Upside: +46.98%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $161.20
Upside: +84.24%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $190.23
Upside: +27.21%
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $271.89
Upside: +137.96%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $1.99
Upside: +88.92%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $293.43
Upside: +105.84%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $482.47
Upside: -22.27%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $15.73
Upside: -1.46%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $279.18
Upside: -3.29%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $11.16
Upside: +38.89%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $246.18
Upside: +117.73%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $22.39
Upside: +29.52%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $155.04
Upside: +30.93%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $176.41
Upside: +71.19%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $7.42
Upside: +3,242.32%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.63
Upside: -